title: Arginine administration to critically ill patients with a low nitric oxide fraction in the airways: a pilot study.
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Tadié
authors.forename: Luc
authors.initials: L
authors.lastname: Cynober
authors.forename: Vincent
authors.initials: V
authors.lastname: Peigne
authors.forename: Aurore
authors.initials: A
authors.lastname: Caumont-Prim
authors.forename: Nathalie
authors.initials: N
authors.lastname: Neveux
authors.forename: Alain
authors.initials: A
authors.lastname: Gey
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Guerot
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Diehl
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Fagon
authors.forename: Eric
authors.initials: E
authors.lastname: Tartour
authors.forename: Christophe
authors.initials: C
authors.lastname: Delclaux
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001120:Arginine / Q000627:therapeutic use*; D003422:Critical Care; D016638:Critical Illness / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism*; D010865:Pilot Projects; D012137:Respiratory System / Q000378:metabolism*
chemical_list: D009569:Nitric Oxide; D001120:Arginine